Search Results

Business

Corealis inaugurates its new facilities in the heart of the Laval Science Park

In the presence of the esteemed Christopher Skeete, Minister for the Economy, and Christine Poirier, Laval City Councillor, , Corealis Pharma Inc. proudly inaugurates the expansion of its facilities nestled in the heart of Laval’s Biotech City.

June 10, 2024

·

3 min read

Deals

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. today announced that it has agreed to acquire all of the non-real estate business assets of Occy Laboratory Inc., (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).

June 20, 2024

·

5 min read

Deals

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. today announced that it has concluded the asset purchase agreement (the “Purchase Agreement”) to acquire all of the non-real estate business assets of Occy Laboratory Inc. (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).

June 26, 2024

·

4 min read

Job Trends

MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY

Moderna today announced the completion of construction of its state-of-the art mRNA manufacturing facility in Laval, Quebec.

February 23, 2024

·

5 min read

Antimicrobial button LIBU’s efficiency confirmed in deactivating the influenza virusTests carried out at the CHU de Québec-Université Laval Research Center

Canadian company GRB Technologies today unveiled the results of a study of the LIBU germicidal elevator button conducted by the CHU de Québec-Université Laval Research Center.

September 29, 2021

·

3 min read

Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204

Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel of Laval University, a world expert on Tau pathology.

March 25, 2024

·

4 min read

Policy

Laser Medical Canada of Laval, Quebec, fined $68,593 for offences under the Food and Drugs Act and Medical Devices Regulations

Laser Medical Canada of Laval, Quebec, has pleaded guilty to charges related to illegally selling and advertising unlicensed medical devices, providing false statements to Health Canada inspectors, and interfering with seized products.

January 26, 2022

·

1 min read

Valbiotis Announces the Implementation of the TOTUM•63 Mode of Action Clinical Study by INAF1 at Laval University in Quebec City, in Partnership With Nestlé Health Science

Valbiotis announces the implementation of the TOTUM•63 mode of action clinical study by the Institute of nutrition and functional foods at Laval University in Quebec City, in partnership with Nestlé Health Science.

June 28, 2021

·

8 min read

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders - June 21, 2023

Crescita Therapeutics Inc. today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 20, 2023.

June 21, 2023

·

1 min read

Business

Endoceutics, Université Laval, and CHU de Québec settle their disputes

Endoceutics Inc., Université Laval, and CHU de Québec-Université Laval are pleased to announce that they have reached an agreement to resolve all their disputes with respect to economic benefits deriving from research.

March 27, 2019

·

4 min read